Inari Medical Inc (NARI)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Net income (ttm)	US$ in thousands	-1,636	-2,769	-16,084	-28,356	-29,267	-22,362	-15,013	-758	9,840	15,718	25,018	17,146
Total stockholders’ equity	US$ in thousands	464,910	452,142	435,645	426,736	417,002	415,099	413,778	418,812	239,209	234,370	221,821	213,611	200,254	191,484	183,870
ROE		-0.35%	-0.61%	-3.69%	-6.64%	-7.02%	-5.39%	-3.63%	-0.18%	4.11%	6.71%	11.28%	8.03%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-1,636K ÷ $464,910K
= -0.35%

Inari Medical Inc's return on equity (ROE) has been fluctuating over the past eight quarters, ranging from -7.02% in Q4 2022 to -0.18% in Q1 2022. ROE indicates how effectively a company is using its shareholders' equity to generate profits. The negative ROE figures suggest that Inari Medical Inc has not been efficiently utilizing its equity to generate returns for shareholders during the analyzed period. The declining trend in ROE from Q1 2022 to Q4 2023 indicates potential challenges in generating profits relative to the shareholders' investment. Further analysis of the company's financial performance and operational efficiency is recommended to identify the underlying factors contributing to the decreasing ROE trend.